Molecular Medicine Partnership Unit Medical Campus of the University of Heidelberg, Germany. Research themes place emphasis on common diseases, particularly blood disorders, cancer, iron metabolism disorders, chronic pain, diseases associated with aging, and AIDS. In 2018 more than 110 scientists from across the world work on these eight research themes: Molecular Medicine Partnership Unit The Molecular Medicine Partnership Unit (MMPU) is an alliance between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of the University of Heidelberg. Its primary aim is to uncover the molecular basis of disease and to speed the transformation of biomedical discoveries into personalized medicine strategies. Founded in
Philosophy of medicine the raison d’être of psycho-pharmacology), but does not permit mind to have any effect on matter. This then means that medical science has difficulty in entertaining even the possibility that placebo effects are real, exist and may be objectively determinable and finding such reports difficult if not impossible to comprehend and/or accept. Yet such reports which appear to be genuine pose a threat to Cartesian dualism which provides the ontological underpinning for biomedicine especially in its clinical domain. Although most areas of study within the Philosophy of Medicine are concerned with matters of epistemology, there is a growing interest in